Case Report | FH-Deficient Uterine Leiomyomas: Pathological Insights into a Rare Tumor.

GC demonstrates improved efficacy compared to GCa in terms of PFS and OS, although this comes with renal toxicity. GCa can be a reasonable option for patients not receiving cisplatin.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-05-01
Primary Topic
Uterine Myomas and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report | FH-Deficient Uterine Leiomyomas: Pathological Insights into a Rare Tumor.

Arpit Jain, Siddhant Swamy, Varun Goel, Nivedita Patnaik et al.
PubMed
Uterine Myomas and Treatments
article

Case Report | FH-Deficient Uterine Leiomyomas: Pathological Insights into a Rare Tumor.

Arpit Jain, Siddhant Swamy, Varun Goel, Nivedita Patnaik, Dharmistha Basu, Vineet Talwar, Sudhir Rawal
article en

Abstract

GC demonstrates improved efficacy compared to GCa in terms of PFS and OS, although this comes with renal toxicity. GCa can be a reasonable option for patients not receiving cisplatin.

PubMedVol. 1(48)
Max Super Speciality Hospital (IN), Rajiv Gandhi Cancer Institute and Research Centre (IN), BLK Super Speciality Hospital (IN)
Good health and well-being
Openalex Percentile: Top 21%
Uterine Myomas and Treatments
OpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Case Report | FH-Deficient Uterine Leiomyomas: Pathological Insights into a Rare Tumor. — Arpit Jain, Siddhant Swamy, et al. · PubMed (2025) | TGRS Research Map | TGRS